辽宁医学杂志2024,Vol.38Issue(1) :64-67.

不同剂量米非司酮治疗对子宫肌瘤患者瘤体体积、血清激素、血液流变学的影响

Effects of different doses of mifepristone on tumor volume,serum hormones and hemorheology in patients with uterine fibroids

徐亚晓 伊孟娜 李轻霞
辽宁医学杂志2024,Vol.38Issue(1) :64-67.

不同剂量米非司酮治疗对子宫肌瘤患者瘤体体积、血清激素、血液流变学的影响

Effects of different doses of mifepristone on tumor volume,serum hormones and hemorheology in patients with uterine fibroids

徐亚晓 1伊孟娜 1李轻霞1
扫码查看

作者信息

  • 1. 河南平顶山郏县妇幼保健院(河南平顶山 467100)
  • 折叠

摘要

目的 探讨不同剂量米非司酮治疗对子宫肌瘤患者瘤体体积、血清激素、血液流变学的影响.方法 选取2019年2月~2021年2月我院子宫肌瘤患者113例,按照随机数字表法分为对照组(n=55)与观察组(n=58),两组均在常规治疗的基础上给予米非司酮,对照组采用大剂量25mg米非司酮治疗对子宫肌瘤,观察组采用小剂量12mg米非司酮治疗对子宫肌瘤,比较两组治疗2个月前后子宫肌瘤体积的变化、血清激素孕酮(progesterone,P)水平、雌激素(estrogen,E2)、黄体生成素(luteinizing hormone,LH)、卵泡刺激激素(follicle-stimulating hormone,FSH)、血液流变学的变化及不良反应.结果 治疗后观察组子宫肌瘤体积小于对照组,治疗后观察组P、E2、LH、FSH的血清激素水平低于对照组,差异具有统计学意义(P<0.05).治疗后观察组全血黏度高切、全血黏度低切及血小板聚集低于对照组,差异具有统计学意义(P<0.05).观察组不良反应总发生率低于对照组,差异具有统计学意义(P<0.05).结论 不同剂量米非司酮都可用于子宫肌瘤治疗,但是小剂量米非司酮的治疗对降低血清激素水平与血流动力学数值更加显著,治疗安全性较好.

Abstract

Objective To investigate the effects of different doses of mifepristone on tumor volume,serum hormones and hemorheology in patients with uterine fibroids.Methods A total of 113 patients with uterine fibroids admitted to our hospi-tal from February 2019 to February 2021 were selected and divided into a control group(n=55)and an observation group(n=58)according to the random number table.Both groups were given mifepristone on the basis of conventional treatment.The control group was treated with high-dose mifepristone(25 mg)for uterine fibroids,and the observation group was treated with low-dose mifepristone(12 mg)for uterine fibroids.The changes of uterine fibroid volume,serum hormone progesterone(P)level,estrogen(E2),luteinizing hormone(LH),follicle stimulating hormone(FSH),hemorheology and adverse reac-tions before and after 2 months of treatment were compared between the two groups.Results After treatment,the volume of hysteromyoma in the observation group was smaller than that in the control group,and the observation group had lower serum hormone levels of P,E2,LH and FSH than the control group(P<0.05).After treatment,the observation group had lower hemodynamic indexes of high blood viscosity,low blood viscosity and platelet aggregation than the control group(P<0.05).Compared with the control group,the observation group had lower total incidence of adverse reactions(P<0.05).Conclusion Different doses of mifepristone can be used in the treatment of hysteromyoma,but the treatment of low-dose mifepristone is more significant in reducing serum hormone level and hemodynamic value,and the treatment safety is better.

关键词

米非司酮/子宫肌瘤患者/子宫肌瘤体积/血清激素/血液流变学

Key words

Mifepristone/Patients with uterine fibroids/Volume of uterine fibroids/Serum hormones/Hemorheology

引用本文复制引用

出版年

2024
辽宁医学杂志
辽宁省医学会

辽宁医学杂志

影响因子:0.339
ISSN:1001-1722
被引量1
参考文献量16
段落导航相关论文